Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleran

Showing results (21-30 of 315) with videos related to

Pageof 32
Sort By:
Future Cardiology|October 7, 2009
Rimonabant: a novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid systemKathleen Colleran, Hemanth Pai
Proceedings. Biological Sciences|April 24, 2015
Social network- and community-level influences on contraceptive use: evidence from rural PolandHeidi Colleran, Ruth Mace
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2017
Don't think twice: BMS is never niceRoisin Colleran, Adnan Kastrati
Circulation|June 23, 2020
Polymer-Free Drug-Eluting Stents: The Importance of the Right ControlRóisín Colleran, Robert A Byrne
The Biochemical Journal|October 1, 1970
Non-enzymic nature of the pyridine haemochrome-cleaving activity of mammalian tissue extracts ('haem alpha-methenyl oxygenase')E Colleran, P O Carra
Revista Espanola De Cardiologia (English Ed.)|May 10, 2016
Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert HandsRoisin Colleran, Robert A Byrne
JACC. Cardiovascular Interventions|March 19, 2021
Choice of Primary Endpoint for Trials Comparing Balloon Angioplasty and StentingRobert A Byrne, Róisín Colleran
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1979
Comparative aspects of bile pigment formation and excretionE Colleran, K P Heirwegh
JACC. Cardiovascular Interventions|November 23, 2019
Shedding Light on the Optimal Management of Patients Presenting With Transient ST-Segment ElevationRobert A Byrne, Roisin Colleran
Journal of Bacteriology|February 1, 1992
Restriction endonuclease mapping of the HI2 incompatibility group plasmid R478K F Whelan, E Colleran
Pageof 32

Showing results (21-30 of 315) with videos related to

Sort By:
Pageof 32
Future Cardiology|October 7, 2009
Rimonabant: a novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid systemKathleen Colleran, Hemanth Pai
Proceedings. Biological Sciences|April 24, 2015
Social network- and community-level influences on contraceptive use: evidence from rural PolandHeidi Colleran, Ruth Mace
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2017
Don't think twice: BMS is never niceRoisin Colleran, Adnan Kastrati
Circulation|June 23, 2020
Polymer-Free Drug-Eluting Stents: The Importance of the Right ControlRóisín Colleran, Robert A Byrne
The Biochemical Journal|October 1, 1970
Non-enzymic nature of the pyridine haemochrome-cleaving activity of mammalian tissue extracts ('haem alpha-methenyl oxygenase')E Colleran, P O Carra
Revista Espanola De Cardiologia (English Ed.)|May 10, 2016
Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert HandsRoisin Colleran, Robert A Byrne
JACC. Cardiovascular Interventions|March 19, 2021
Choice of Primary Endpoint for Trials Comparing Balloon Angioplasty and StentingRobert A Byrne, Róisín Colleran
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1979
Comparative aspects of bile pigment formation and excretionE Colleran, K P Heirwegh
JACC. Cardiovascular Interventions|November 23, 2019
Shedding Light on the Optimal Management of Patients Presenting With Transient ST-Segment ElevationRobert A Byrne, Roisin Colleran
Journal of Bacteriology|February 1, 1992
Restriction endonuclease mapping of the HI2 incompatibility group plasmid R478K F Whelan, E Colleran
Pageof 32